Dr. Jain is the leading expert in the urine liquid biopsy field with 10 years of R&D experience in developing biomarkers for diagnosis and monitoring of liver cancer. Dr. Jain joined JBS Science in 2013 and has been instrumental in the development of a urine DNA test for liver cancer screening. Prior to joining JBS, she received her postdoctoral training under Dr. Ying-Hsiu Su, the pioneer of urine DNA technology for cancer detection. Dr. Jain is the recipient of the Prevent Cancer Foundation fellowship and numerous NIH-funded SBIR grants as the lead principal investigator. She has a well-qualified record of successful research projects in the field of non-invasive cancer biomarkers and trans-renal urinary DNA. Dr. Jain brings a unique and vital know-how to serve as Chief Scientific Officer of JBS Science. In this position, she oversees the scientific research operations, recruitment and management of the scientific team, as well as exploration of new research opportunities and strategies. Overall, Dr. Jain ensures that our research arm is aligned with the mission and the goals of the company.